Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05964140Phase 3Recruiting
Phase 3, randomised, open-label trial of amoxicillin + clavulanate in Mandible fracture (3 arms), sponsored by East Lancashire Hospitals NHS Trust. Primary endpoint: Surgical Site Infection at 30 days. Started Dec 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05964140.